N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine

C71H81N23O4S5 — CID 157061166

IUPACN-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine
SMILESCc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(CS(C)(=O)=O)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(N)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NCCN2CCS(=O)(=O)CC2)s1
InChIInChI=1S/C25H29N7O2S2.C23H26N8O2S2.C23H26N8S/c1-16-30-31-25(35-16)22-13-26-23(19-6-4-5-18(11-19)20-12-27-32(2)14-20)29-24(22)28-21-9-7-17(8-10-21)15-36(3,33)34;1-16-28-29-23(34-16)20-14-25-21(18-5-3-4-17(12-18)19-13-26-30(2)15-19)27-22(20)24-6-7-31-8-10-35(32,33)11-9-31;1-14-29-30-23(32-14)20-12-25-21(28-22(20)27-19-8-6-18(24)7-9-19)16-5-3-4-15(10-16)17-11-26-31(2)13-17/h4-6,11-14,17,21H,7-10,15H2,1-3H3,(H,26,28,29);3-5,12-15H,6-11H2,1-2H3,(H,24,25,27);3-5,10-13,18-19H,6-9,24H2,1-2H3,(H,25,27,28)
InChIKeyABIRNLDXQMAWEG-UHFFFAOYSA-N
MW1480.92 g/mol
LogP10.95
Rot. Bonds19

About N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine

N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine (PubChem CID 157061166) has the molecular formula C71H81N23O4S5 and a molecular weight of 1480.92 g/mol. Its IUPAC name is N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine.

Molecular Properties

Compound NameN-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine
PubChem CID157061166
Molecular FormulaC71H81N23O4S5
Molecular Weight1480.92 g/mol
Exact Mass1479.54
IUPAC NameN-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine
SMILESCc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(CS(C)(=O)=O)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(N)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NCCN2CCS(=O)(=O)CC2)s1
InChIInChI=1S/C25H29N7O2S2.C23H26N8O2S2.C23H26N8S/c1-16-30-31-25(35-16)22-13-26-23(19-6-4-5-18(11-19)20-12-27-32(2)14-20)29-24(22)28-21-9-7-17(8-10-21)15-36(3,33)34;1-16-28-29-23(34-16)20-14-25-21(18-5-3-4-17(12-18)19-13-26-30(2)15-19)27-22(20)24-6-7-31-8-10-35(32,33)11-9-31;1-14-29-30-23(32-14)20-12-25-21(28-22(20)27-19-8-6-18(24)7-9-19)16-5-3-4-15(10-16)17-11-26-31(2)13-17/h4-6,11-14,17,21H,7-10,15H2,1-3H3,(H,26,28,29);3-5,12-15H,6-11H2,1-2H3,(H,24,25,27);3-5,10-13,18-19H,6-9,24H2,1-2H3,(H,25,27,28)
InChIKeyABIRNLDXQMAWEG-UHFFFAOYSA-N
XLogP10.95
TPSA341.77 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds19
Heavy Atoms103
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001480.92
LogP ≤ 510.95
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Analyze N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine?
The IUPAC name of N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine (CID 157061166) is N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine.
What is the SMILES notation for N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine?
The canonical SMILES for N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine is Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(CS(C)(=O)=O)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NC2CCC(N)CC2)s1.Cc1nnc(-c2cnc(-c3cccc(-c4cnn(C)c4)c3)nc2NCCN2CCS(=O)(=O)CC2)s1.
What is the InChIKey of N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine?
The InChIKey is ABIRNLDXQMAWEG-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29N7O2S2.C23H26N8O2S2.C23H26N8S/c1-16-30-31-25(35-16)22-13-26-23(19-6-4-5-18(11-19)20-12-27-32(2)14-20)29-24(22)28-21-9-7-17(8-10-21)15-36(3,33)34;1-16-28-29-23(34-16)20-14-25-21(18-5-3-4-17(12-18)19-13-26-30(2)15-19)27-22(20)24-6-7-31-8-10-35(32,33)11-9-31;1-14-29-30-23(32-14)20-12-25-21(28-22(20)27-19-8-6-18(24)7-9-19)16-5-3-4-15(10-16)17-11-26-31(2)13-17/h4-6,11-14,17,21H,7-10,15H2,1-3H3,(H,26,28,29);3-5,12-15H,6-11H2,1-2H3,(H,24,25,27);3-5,10-13,18-19H,6-9,24H2,1-2H3,(H,25,27,28).
What are the key properties of N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine?
N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine has a molecular weight of 1480.92 g/mol, XLogP of 10.95, 19 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;2-[3-(1-methylpyrazol-4-yl)phenyl]-N-[4-(methylsulfonylmethyl)cyclohexyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-amine;4-N-[2-[3-(1-methylpyrazol-4-yl)phenyl]-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidin-4-yl]cyclohexane-1,4-diamine is sourced from PubChem (CID 157061166), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).